Innovative Industrial Properties, Inc.

Innovative Industrial Properties, Inc. (IIPR) Market Cap

Innovative Industrial Properties, Inc. has a market capitalization of $1.69B.

Price: $58.56

0.16 (0.27%)

Market Cap: 1.69B

NYSE · time unavailable

CEO: Paul E. Smithers

Sector: Real Estate

Industry: REIT - Industrial

IPO Date: 2016-12-01

Website: https://www.innovativeindustrialproperties.com

Innovative Industrial Properties, Inc. (IIPR) - Company Information

Market Cap: 1.69B|Sector: Real Estate

Company Profile

Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties, Inc. has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017.

Analyst Sentiment

57%
Buy

From 6 Active Polls

1Y Forecast: $84.67

▲ +44.6% Potential Upside

Consensus Target Metrics

Low Bound

$44

Median

$60

High Bound

$150

Average

$85

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$84.67
▲ +44.59% Upside
Low Target
$44.00
-25% Risk
Median Target
$60.00
2% Mid
High Target
$150.00
156% Max
Consensus
Hold
4 / 11 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)1,6851,4041,3221,4961,5421,5291,8833,8033,044
Enterprise Value ($M)1,9621,6811,6681,7991,7321,6912,0353,9533,220
Price to Earnings Ratio (P/E)13.6610.7010.3812.7614.8112.3011.7623.6418.12
Price/Earnings-to-Growth Ratio (PEG)3.053.404.4741.283.15
Price to Sales Ratio (P/S)6.4020.3519.8323.1224.5221.3224.5349.7038.15
Price to Book Ratio (P/B)0.870.740.720.800.820.800.971.951.56
Price to Free Cash Flow Ratio (P/FCF)8.5526.4526.4932.8031.8328.2046.3558.6347.41
Enterprise Value to Sales (EV/Sales)24.3625.0227.8127.5423.5826.5151.6640.36
Enterprise Value to EBITDA (EV/EBITDA)9.0729.0729.2134.2935.3731.3333.1563.1750.49
Debt to Equity Ratio1.280.190.210.180.150.150.150.150.15

IIPR Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$58.56
Intrinsic Value$84.16
Market Alignment
Undervalued by 43.7%relative to calculated intrinsic value
9.00%
Exp: -2%-2%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.17B
Perpetuity TV Value$3.22B
Discounted TV (PV)$1.36B
TV Weighting %56.4%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 INNOVATIVE INDUSTRIAL PROPERTIES I (IIPR) — Investment Overview

🧩 Business Model Overview

IIPR is a specialized REIT that owns and operates industrial real estate tailored to regulated cannabis uses. The core “how it works” is straightforward: IIPR sources and structures facilities for licensed operators (often through sale-leaseback and build-to-suit transactions), then monetizes the properties via long-duration leases that transfer a substantial portion of operating costs to tenants.

This model creates operational stickiness because the assets are not generic warehouses; they are typically configured for compliance-oriented cultivation/processing requirements, with lease structures designed around the tenant’s need for continuity of location, permitting alignment, and operational readiness.

💰 Revenue Streams & Monetisation Model

Revenue is primarily rental income under lease agreements. The monetisation mix is structurally lease-driven rather than property-sale-driven: rent streams tend to be recurring, supported by lease terms that often include fixed contractual escalators and tenant responsibility for many ongoing property expenses.

Margin drivers are largely “REIT economics”:

  • Lease durability: Long lease terms can smooth rental cash flows relative to cyclical real estate segments.
  • Escalation mechanics: Contractual rent growth can partially offset inflationary pressures.
  • Expense pass-through: Triple-net style components (or close equivalents) reduce operating cost variability for IIPR.
  • Capital allocation discipline: Profitability depends on acquisition/build returns relative to the cost of capital and the quality of tenant covenants.

🧠 Competitive Advantages & Market Positioning

IIPR’s competitive positioning is best understood as a specialist landlord with regulatory and design experience in cannabis-adjacent industrial real estate. The moat is less about “owning land” and more about building a repeatable ability to place capital into compliant facilities and secure long-term tenant occupancy.

Moat thesis:

  • Switching costs (tenant operational continuity): Moving cannabis operations is not just a lease move; it can require new equipment layouts, licensing alignment, permitting, and operational ramp-up—making tenants value location continuity.
  • Specialized property configuration & execution: Purpose-fit facilities and landlord know-how lower execution risk for operators compared with negotiating generic industrial space conversions.
  • Regulatory/structural barriers: Competitors without cannabis-specific underwriting capability face higher due diligence friction and greater uncertainty around tenant compliance and lease durability.

Competitive benchmarking (industrial real estate alternatives):

  • Prologis (PLD): Large-scale industrial operator with broad exposure to logistics real estate; typically focuses on diversified, non-cannabis-specific tenant needs.
  • First Industrial Realty Trust (FR) / Duke Realty (DRE): Industrial REIT peers with conventional logistics and light industrial positioning rather than cannabis-specialist build and leasing workflows.
  • Private industrial landlords / local commercial owners: Often compete on availability of general space, but may lack the standardized, cannabis-execution discipline that supports tenant continuity and lease structure.

Compared with these rivals, IIPR’s market focus is narrower: cannabis-oriented industrial facilities and sale-leaseback/build-to-suit transactions for licensed operators. That specialization can raise barriers for generalized industrial landlords that must balance underwriting, compliance know-how, and tenant concentration risk.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, IIPR’s growth potential is tied to the maturation of regulated cannabis markets and the industry’s need for scaled, compliant real estate.

  • Market legalization and re-licensing breadth: As more jurisdictions permit regulated activity, operators require compliant capacity, not just raw land.
  • Facility professionalization: The industry trend toward more standardized cultivation/processing and tighter compliance creates demand for purpose-built or expertly adapted facilities.
  • Operator consolidation: As the market consolidates, larger operators often need stable facility footprints with operational continuity—supporting longer landlord-tenant relationships.
  • Capital markets access and deal repeatability: Specialized REIT structures can repeatedly finance acquisitions/builds that generalized landlords may not underwrite at scale.

⚠ Risk Factors to Monitor

  • Regulatory and policy risk: Changes to licensing rules, compliance requirements, or enforcement priorities can affect tenant viability and the realizable value of facilities.
  • Tenant concentration and credit risk: Cannabis operators can face volatility from pricing, demand fluctuations, and financing constraints; lease collectability and covenant strength matter.
  • Obsolescence and repositioning risk: If facility designs become less aligned with evolving regulatory/compliance needs, asset re-tenanting may be slower or require incremental capital.
  • Capital intensity and interest-rate sensitivity: New acquisitions/builds depend on financing conditions and disciplined underwriting; leverage and cost of capital can affect per-deal returns.
  • Reputation and compliance administration: Landlord risk increases if tenant compliance failures cascade into rent collection or lease enforcement complexity.

📊 Valuation & Market View

The market typically values IIPR-like REITs using a REIT lens, where value is driven by cash-flow durability and the quality of contracted rent rather than pure real estate “turn” economics. Common valuation frameworks include:

  • Cash flow multiples: Investors often anchor on AFFO-/FFO-like earnings power and the sustainability of rent growth and occupancy.
  • Balance sheet and cost of capital: Leverage, interest-rate environment, and access to financing influence distributable cash flow.
  • Property-level drivers: Lease duration, credit quality, tenant retention, and expense pass-through strength can move valuation more than broad industrial REIT comps.

Key valuation sensitivities for this business model are the perceived durability of lease cash flows and the expectation for stable reinvestment returns across new facilities.

🔍 Investment Takeaway

IIPR offers an evergreen, specialist REIT thesis: a narrow underwriting focus on cannabis-oriented industrial facilities can generate structural tenant stickiness through switching costs and operational continuity, reinforced by regulatory and execution barriers that general industrial landlords face. Long-duration lease economics, expense pass-through dynamics, and deal repeatability underpin the investment case, while the primary risks remain regulatory uncertainty, tenant credit cycles, and facility repositioning sensitivity as cannabis regulations and operating models evolve.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for IIPR.

zacks.com2026-06-03

Why Is Innovative Industrial Properties (IIPR) Down 3.9% Since Last Earnings Report?

Innovative Industrial Properties (IIPR) reported earnings 30 days ago. What's next for the stock?

zacks.com2026-05-27

What IIPR's $282M Senior Note Repayment Means for Investors in 2026

IIPR repays $282M of 5.50% notes due May 2026, easing refinancing pressure and boosting flexibility as it leans on new secured loans.

gurufocus.com2026-05-26

Innovative Industrial Properties Announces Full Repayment of $282 Million of Senior Notes

Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR) announced today it has fully repaid its outstanding $282 million of 5.50% Senior Notes Due May 2026,

businesswire.com2026-05-26

Innovative Industrial Properties Announces Full Repayment of $282 Million of Senior Notes

SAN DIEGO--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR) announced today it has fully repaid its outstanding $282 million of 5.50% Senior Notes Due May 2026, satisfying a significant public debt maturity for the Company. The repayment was completed through cash on hand, availability under the Company's revolving credit facilities and proceeds from recently closed term loans. “Repaying this bond maturity represents a meaningful milestone for IIP, which reflects the s.

seekingalpha.com2026-05-24

Innovative Industrial Properties: Dual Beats And Fat Dividend Yield From Most Undervalued REIT

Innovative Industrial Properties is undervalued, trading at 8x 2026 annualized first-quarter NFFO versus peers at 14.37x. IIPR's 13.32% dividend yield is not currently covered, but ongoing tenant default resolutions and new leases are expected to improve NFFO coverage and support the payout. Recent leasing momentum and increased payments from defaulted tenants underpin sequential revenue growth, with second-quarter revenue likely to exceed $70 million.

marijuanastocks.com2026-05-21

Cannabis REITs Gaining Momentum in 2026: 3 Stocks to Watch

The cannabis sector continues attracting investors in 2026. However, many traders now prefer cannabis REITs over traditional marijuana stocks. These companies offer exposure to the industry while also generating income through dividends. Additionally, cannabis REITs typically exhibit lower volatility than many cannabis operators.

businesswire.com2026-05-20

Innovative Industrial Properties Announces Closing of $45 Million in Secured Term Loans

SAN DIEGO--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR) announced today it has closed on four secured term loans totaling $44.9 million in gross proceeds (the “Loans”). The Loans have an initial term of five years, bear interest at a fixed rate of 6.67% and are secured by certain properties of the Company. The proceeds from the Loans are expected to be used to pay off the Company's unsecured notes that are maturing at the end of this month. “This financing reflects.

marketbeat.com2026-05-10

Innovative Industrial Properties Q1 Earnings Call Highlights

Innovative Industrial Properties NYSE: IIPR reported first-quarter 2026 revenue of $69 million and adjusted funds from operations of $53.4 million, or $1.88 per share, as executives said the company is working to stabilize its cannabis real estate portfolio, refinance a near-term bond maturity and position itself for growth amid changes in federal cannabis policy.

seekingalpha.com2026-05-07

Innovative Industrial Properties: Gradual Recovery That I Believe In

Innovative Industrial Properties, Inc. remains a Buy after a ~78% drop since 2022, supported by recent solid earnings and attractive valuation. IIPR's triple-net lease model, 110-property portfolio, and 12.4-year WALT provide predictable cash flows and operational resilience. With a 7% AFFO per share CAGR and 9% annual DPS growth, IIPR offers compelling, growing dividends for income-focused investors.

247wallst.com2026-05-07

High yield ETF KBWY faces hidden payout risk from cannabis REIT tenant defaults

The Invesco KBW Premium Yield Equity REIT ETF (NASDAQ:KBWY) concentrates in roughly 30 small and mid-cap REITs that pass a high-yield screen.

247wallst.com2026-05-07

5% Yield Hides a Problem: XSHD Holdings Cut Dividends Faster Than Share Prices Fall

The Invesco S&P SmallCap High Dividend Low Volatility ETF (NASDAQ:XSHD) promises small-cap yield with smoother price action.

seekingalpha.com2026-05-06

Innovative Industrial Properties: Medical Cannabis Rescheduling Implies Bottoming Tenant Default Risks - Reiterate Buy

IIPR navigates ongoing tenant defaults and elevated AFFO payout ratio, with the management funding dividends through stock issuance and debt amid deteriorating balance sheet. Recent federal medical cannabis rescheduling offers potential bottom-line relief for the REIT's tenants, supporting future rental collections and moderating default risks. IIPR's valuation floor at Price/AFFO of ~7x and the management's dividend commitment underpin a high-risk, high-yield contrarian income thesis.

businesswire.com2026-05-06

Innovative Industrial Properties Announces Closing of $56.5 Million Secured Term Loan

SAN DIEGO--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR) announced today it has closed on a $56.5 million secured term loan (the “Loan”). The Loan has an initial term of three years, bears interest at the one-month Secured Overnight Financing Rate (SOFR) plus a spread of 500 basis points, is interest only and is secured by certain properties of the Company. The proceeds from the Loan are expected to be used to pay off the Company's unsecured notes that are maturing.

seekingalpha.com2026-05-06

Innovative Industrial Properties: High Yield At Low Leverage

Innovative Industrial Properties offers a compelling AFFO yield of 13.7% on common stock and over 10% current yield on preferreds. IIPR trades at a P/B of 0.91, reflecting market skepticism due to troubled tenants and cannabis sector uncertainty despite strong asset coverage and low leverage. Portfolio diversification into life sciences increases credit risk, with new investments yielding 14% but reducing fixed charge coverage and raising Net Debt/EBITDA to 2.09x.

seekingalpha.com2026-05-05

Innovative Industrial Properties, Inc. (IIPR) Q1 2026 Earnings Call Transcript

Innovative Industrial Properties, Inc. (IIPR) Q1 2026 Earnings Call Transcript

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"IIPR reported Q1 2026 Revenue of $68.999M and Net Income of $30.155M (EPS $1.08; diluted $1.02). YoY, Revenue declined from $71.722M in Q1’25 to $68.996M in Q1’26 (about -3.8%), while Net Income rose from $31.077M to $30.155M (about -3.0%). QoQ, Revenue increased from $66.657M in Q4’25 to $68.996M in Q1’26 (+3.5%), and Net Income fell from $31.841M to $30.155M (-5.3%). Profitability remains very strong for this period, with Q1’26 gross margin at ~89.0% and net margin at ~43.7%. Across the last four quarters, gross margin stayed high but has been somewhat volatile (notably lower in Q4’25). Net margin contracted vs Q4’25 (47.8% to 43.7%), suggesting costs/other line items were less favorable sequentially. Cash generation was solid: operating cash flow was $56.031M and free cash flow was $56.031M. The company paid $1.002M in dividends and had no common buybacks reported in Q1’26. Balance sheet resilience is supported by sizable cash ($89.1M) and stable equity ($1.895B), though leverage remains meaningful with long-term debt of $366.0M. Total shareholder returns are modest based on available performance data: the stock is up ~3.9% over the last year and shows no buyback support in Q1’26. With limited dividend yield (~0.07%), appreciation appears to be the primary driver, but momentum is not strong (<20% 1y)."

Revenue Growth

Neutral

QoQ Revenue increased +3.5% ($66.657M to $68.996M) but YoY Revenue decreased about -3.8% ($71.722M to $68.996M), indicating mild contraction with some sequential improvement.

Profitability

Positive

Gross margin remains very high (~89.0%) but net margin contracted QoQ (47.8% in Q4’25 to 43.7% in Q1’26). YoY net income is slightly lower (~-3.0%), implying profitability softened sequentially.

Cash Flow Quality

Positive

Operating cash flow was strong at $56.0M with free cash flow equal to $56.0M in Q1’26. Dividends paid were relatively small ($1.0M) versus net income, supporting coverage and optionality.

Leverage & Balance Sheet

Fair

Equity was stable and sizable ($1.895B) while total assets were steady (about $2.394B). Debt remains material (long-term debt $366.0M; net debt ~$276.9M), so balance sheet strength is moderate rather than defensive.

Shareholder Returns

Fair

No evidence of buybacks in Q1’26 and dividends appear small (dividend yield ~0.07%). Stock performance is positive but not momentum-driven (+3.9% 1y_change), limiting total return support.

Analyst Sentiment & Valuation

Positive

Valuation multiples shown are reasonable for the current profitability (e.g., P/E ~11.6, price-to-book ~0.74). Analyst target consensus ($84.67) implies upside to the current price (~$52.94), supporting sentiment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

IIPR’s Q1 2026 results were supported by portfolio monetization events tied to tenant restructurings and stabilized leasing. Revenues rose to $69.0m (+3.5% vs Q4) mainly from PharmaCann payments ($3.2m), while AFFO was $53.4m ($1.88/share), in line with the prior quarter. Management’s key narrative is the transition to federal Schedule III for qualifying medical operators, which they view as the biggest industry catalyst since 2016, potentially eliminating 280E for medical operators and improving operator economics and capital access. Operationally, leasing progress is tangible but execution timing remains dependent on licensing and approvals: Gold Flora is fully re-leased; 4Front is largely stabilized via tentative agreements (~488k sf) tied to receivership conclusion; PharmaCann is resolved and re-leased with new tenants (Grown Rogue, Curaleaf). Financially, the company is actively de-risking its unsecured bond maturity with $128m raised year-to-date and multiple ~8% blended-rate financings (~$130m total) pending closure, while liquidity remains strong (~$177m).

AI IconGrowth Catalysts

  • DOJ/ag acting Attorney General final order moving FDA-approved medical cannabis products (and state-licensed medical operators’ cannabis) to Schedule III, eliminating 280E burden for qualifying medical operators and setting expedited DEA hearing timeline
  • Texas Compassionate Use Program awarding conditional licenses to tenant partners Green Thumb Industries and Cresco Labs, expanding in-state medical program footprint
  • Portfolio leasing momentum: 4 new leases totaling ~331,000 sq ft signed in Q1, plus earlier execution/stabilization across Gold Flora, PharmaCann, and 4Front assets

Business Development

  • IQHQ life science JV/commitment: $175 million funded to date of a $270 million commitment
  • Texas Compassionate Use Program: conditional licenses awarded to Green Thumb Industries and Cresco Labs (plus mentions of Texas Original, Trulieve, Verano already in market)
  • Leasing / retenanting and tenant names: Grown Rogue (Dwight, IL), Curaleaf (Ohio, 58,000 sq ft), Battle Green (Columbus, OH; defaulted March), Holistic (Ohio; mentioned by analyst as taking over operations), plus multiple other tenant partners referenced (e.g., PharmaCann resolution, 4Front tentative tenants subject to diligence/licensing)

AI IconFinancial Highlights

  • Total revenues: $69.0 million, +3.5% vs Q4 2025; increase primarily from PharmaCann payments of $3.2 million
  • AFFO: $53.4 million, or $1.88/share, in line with Q4 2025
  • Administrative rents: $1.5 million received in Q1 as settlement of remaining unpaid administrative rents due from Gold Flora receivership
  • Leasing inflows/earnings support: management highlighted triple-net expense transfers upon lease execution as an additional earnings pickup
  • No explicit bps margin change disclosed in transcript; credit metrics emphasized instead (debt service coverage >11x; net debt/adjusted EBITDA 1.1x)

AI IconCapital Funding

  • Raised $128 million of gross proceeds year-to-date (preferred equity $72m, common equity $36m, secured debt $20m via 3-year secured term loan at fixed 9%)
  • Pursuing additional secured/unsecured financings totaling nearly $130 million; $56.5 million financing expected to be funded today with stated rate 8.75%
  • Blended rate of just over 8% expected based on terms under discussion (subject to contingencies/closing)
  • Liquidity as of March 31: ~$177 million total (cash $89m; revolver availability $87.5m)
  • Primary capital objective: address unsecured bond maturity this month; management positioned balance sheet for growth in 2026

AI IconStrategy & Ops

  • Leasing execution in Q1: signed new leases at 4 properties totaling ~331,000 sq ft
  • Gold Flora former assets fully leased: all 3 properties totaling ~330,000 sq ft leased (Palm Springs 70,000 sq ft; Desert Hot Springs 204,000 sq ft; Palm Springs 56,000 sq ft)
  • 4Front stabilization: reached tentative agreements for all 4 properties totaling ~488,000 sq ft (Illinois, Washington, Massachusetts), subject to diligence, licensing approvals, and expected commencement after receivership conclusion later in 2026
  • PharmaCann: resolved all pending litigation related to lease defaults; executed new leases in March/April (Grown Rogue in Dwight, IL; Curaleaf in Ohio) and described active retenanting of returning properties later this month
  • Pennsylvania portfolio: regained possession of a 270,000 sq ft property on April 15 and is in active discussions with a new tenant
  • Columbus, Ohio Battle Green: defaulted in March; company enforcing rights including commencing eviction proceedings and pursuing remedies under applicable guarantees
  • Life science environment: cited stabilization/improving momentum in 2026 with demand near pre-pandemic levels; new development down; pipeline historically low

AI IconMarket Outlook

  • IQHQ investment timing: scheduled investments through mid-2027; management noted ability to bring forward a couple scheduled investments as accretive transactions
  • Rescheduling hearing timeline: expedited process expected to be wrapped within 30 days after hearings begin June 29; management expects clear resolution including medical vs adult-use treatment by conclusion of hearing
  • Near-term priority: complete refinancing of unsecured debt and complete IQHQ commitment before pursuing additional acquisitions for 2H 2026/into 2027

AI IconRisks & Headwinds

  • Persistent inflation, elevated interest rates, and broader macroeconomic headwinds cited as ongoing operating challenges
  • All additional financings are subject to contingencies and not assured to close on contemplated terms
  • Lease commencement risk: free rent periods and licensing/approval timing can delay revenue impact; multiple leases are tentative/nonbinding and subject to receivership/diligence/licensing approvals
  • Tenant credit/workout risk persists even with 280E relief: management stated businesses can still grow/shrink/disappear; 280E improves operating environments but does not eliminate business risk

Q&A: Analyst Interest

  • Leasing timing/modeling: Management explained that executed leases typically require regulatory approval, license transfer, and can include free-rent periods averaging ~3 to 12 months and up to 18 months; they also emphasized that triple-net expense transfers generally occur at lease execution, supporting earnings when rent starts.
  • Schedule III mechanics & 280E: Management clarified that licensed medical operators are covered by Schedule III immediately (100% of its tenants hold medical licenses), while the broadened hearing begins June 29 with an expedited 30-day timeline for adult-use treatment; they expect retroactive 280E relief for qualifying medical operators and noted Treasury guidance may follow sooner.
  • IQHQ incremental investments: Management stated IQHQ preferred/commitment investments are scheduled through mid-2027, with some investments brought forward opportunistically due to accretiveness—average yield north of 14% versus ~6% cost of capital on their credit facility—while reiterating priority on unsecured debt refinancing first before new acquisitions.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the IIPR Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for IIPR.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (IIPR)

© 2026 Stock Market Info — Innovative Industrial Properties, Inc. (IIPR) Financial Profile